Catalyst Wire Dossier Catalyst Wire Dossier

Prostigmin (Neostigmine)

Neostigmine bromide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Prostigmin (Neostigmine), covering 2017-11-01 to 2017-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Combined Use of Low-dose Sugammadex Plus Neostigmine Administered for Reversal of Rocuronium [EARLY_Phase 1]

See pricing